Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

629 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of Osimertinib on CTCs and ctDNA in EGFR Mutant Non-Small Cell Lung Cancer Patients: The Prognostic Relevance of Liquid Biopsy.
Kallergi G, Kontopodis E, Ntzifa A, Jordana-Ariza N, Karachaliou N, Pantazaka E, Charalambous HA, Psyrri A, Tsaroucha E, Boukovinas I, Koumarianou A, Hatzidaki D, Lianidou E, Georgoulias V, Rosell R, Kotsakis A. Kallergi G, et al. Among authors: georgoulias v. Cancers (Basel). 2022 Mar 19;14(6):1574. doi: 10.3390/cancers14061574. Cancers (Basel). 2022. PMID: 35326725 Free PMC article.
First-line treatment of advanced non-small-cell lung cancer with docetaxel and cisplatin: a multicenter phase II study.
Georgoulias V, Androulakis N, Dimopoulos AM, Kourousis C, Kakolyris S, Papadakis E, Apostolopoulou F, Papadimitriou C, Vossos A, Agelidou M, Heras P, Tzannes S, Vlachonicolis J, Mavromanolakis E, Hatzidaki D. Georgoulias V, et al. Ann Oncol. 1998 Mar;9(3):331-4. doi: 10.1023/a:1008278103446. Ann Oncol. 1998. PMID: 9602269 Clinical Trial.
Salvage treatment with paclitaxel and gemcitabine for patients with non-small-cell lung cancer after cisplatin- or docetaxel-based chemotherapy: a multicenter phase II study.
Androulakis N, Kouroussis C, Kakolyris S, Tzannes S, Papadakis E, Papadimitriou C, Geroyianni A, Georgopoulou T, Dimopoulou I, Souglakos J, Kotsakis A, Vardakis N, Hatzidaki D, Georgoulias V. Androulakis N, et al. Among authors: georgoulias v. Ann Oncol. 1998 Oct;9(10):1127-30. doi: 10.1023/a:1008497322508. Ann Oncol. 1998. PMID: 9834827 Free article. Clinical Trial.
Combination chemotherapy with docetaxel, vinorelbine and cisplatin as first-line treatment of advanced non-small-cell lung cancer: a multicenter phase II study of the Greek Cooperative Group for Lung Cancer.
Georgoulias V, Androulakis N, Bouros D, Kouroussis C, Chatzakis K, Papadakis M, Apostopoloulou F, Georgopoulou T, Kotsakis T, Souklakos J, Hatzidaki D, Vlachonikolis J, Panagos G. Georgoulias V, et al. Lung Cancer. 1998 Sep;21(3):213-20. doi: 10.1016/s0169-5002(98)00028-2. Lung Cancer. 1998. PMID: 9857999 Clinical Trial.
Dose-escalation study of docetaxel in combination with mitoxantrone as first-line treatment in patients with metastatic breast cancer.
Kouroussis C, Androulakis N, Kakolyris S, Souglakos J, Kotsakis T, Mavroudis D, Katsogridakis K, Vardakis N, Hatzidaki D, Samonis G, Vlachonikolis J, Georgoulias V. Kouroussis C, et al. Among authors: georgoulias v. J Clin Oncol. 1999 Mar;17(3):862-9. doi: 10.1200/JCO.1999.17.3.862. J Clin Oncol. 1999. PMID: 10071277 Clinical Trial.
Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trial.
Georgoulias V, Kouroussis C, Androulakis N, Kakolyris S, Dimopoulos MA, Papadakis E, Bouros D, Apostolopoulou F, Papadimitriou C, Agelidou A, Hatzakis K, Kalbakis K, Kotsakis A, Vardakis N, Vlachonicolis J. Georgoulias V, et al. J Clin Oncol. 1999 Mar;17(3):914-20. doi: 10.1200/JCO.1999.17.3.914. J Clin Oncol. 1999. PMID: 10071284 Clinical Trial.
629 results